Market: NYQ |
Currency:
Address:
📈 TE Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$10.50
-
Upside/Downside from Analyst Target:
23.53%
-
Broker Call:
10
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
<0%
-
Net Income Growth Range (1Y):
<0%
-
Revenue Growth Range (1Y):
-
-
Upcoming Earnings Date:
-
💰 Dividend History
No dividend history available.
📅 Earnings & EPS History for TE
| Date | Reported EPS |
|---|
| 2025-11-12 | - |
| 2025-08-19 | -0.21 |
| 2025-05-15 | -0.14 |
| 2025-03-17 | -0.21 |
| 2024-11-06 | -0.17 |
| 2024-08-09 | -0.19 |
| 2024-05-08 | -0.22 |
| 2024-02-29 | -0.19 |
| 2023-11-09 | -0.22 |
| 2023-08-10 | -0.22 |
| 2023-05-15 | -0.22 |
| 2023-02-27 | -0.25 |
| 2022-11-14 | -0.8 |
| 2022-08-08 | -0.26 |
| 2022-05-11 | -0.22 |
| 2022-02-28 | -0.15 |
| 2021-11-15 | -0.42 |
| 2021-08-12 | -0.04 |
📰 Related News & Research
-
Shenzhen Woer Heat-Shrinkable Material Co., Ltd. (9981) Announces HKEX IPO Allotment Results, Final Offer Price, Cornerstone Investors & Listing Details
February 14, 2026
Shenzhen Woer Heat-Shrinkable Material Co., Ltd. IPO Analysis: Comprehensive Investor Guide Shenzhen Woer Heat-Shrinkable Material Co., Ltd. Date of Prospectus: February 5, 2026 Bold Move:…
-
Beijing Haizhi Technology Group (2706.HK) Announces Final IPO Offer Price, Allotment Results, and Shareholder Details for Hong Kong Listing
February 14, 2026
Beijing Haizhi Technology Group Co., Ltd. – February 5, 2026 – IPO Analysis Beijing Haizhi Technology Group Co., Ltd. Date of Prospectus: February 5, 2026…
-
Sichuan Biokin Pharmaceutical (688506) Hong Kong IPO: Innovative Oncology Pipeline, Global Strategy & Key Risk Factors Explained
February 14, 2026
Baili Pharmaceutical IPO Analysis: Growth, Strategy & Outlook for Investors Company Name: Baili Pharmaceutical Co., Ltd. Date of Prospectus: November 7, 2025 Baili Pharmaceutical IPO:…
-
Sichuan Biokin Pharmaceutical (2615 HK) IPO: Global Offering Details, Application Process & Key Dates 2025
February 14, 2026
Sichuan Biokin Pharmaceutical Co., Ltd. IPO Analysis: Key Insights for Investors Sichuan Biokin Pharmaceutical Co., Ltd. Date of Prospectus: November 7, 2025 Sichuan Biokin Pharmaceutical:…
-
VOYAH Automotive Technology Lists 885 Million H Shares on Hong Kong Stock Exchange by Introduction – Key Details & Dates 12
February 14, 2026
VOYAH Automotive Technology Co., Ltd. IPO Analysis – Investor Article VOYAH Automotive Technology Co., Ltd. Date of Prospectus: February 13, 2026 VOYAH Automotive’s 2026 Hong…
-
Sanli Environmental Limited Provides Update on Use of Net Proceeds from 2025 Share Placement 1
February 14, 2026
Key Highlights from the Latest Announcement Company: Sanli Environmental Limited (SGX:1E3) Type of Announcement: Update on Utilisation of Placement Proceeds Date of Announcement: 13 February…
-
CASA Holdings Limited 2026 AGM Minutes: Resolutions, Financial Performance, and Strategic Updates
February 14, 2026
Casa Holdings Limited: 2026 AGM Review – Key Developments and Investor Insights Casa Holdings Limited held its Annual General Meeting (AGM) on 23 January 2026…
-
CASA Holdings Limited Extraordinary General Meeting 2026: Adoption of New Constitution and Objects Clause Amendments
February 14, 2026
Date: 23 January 2026 Location: 15 Kian Teck Crescent, Singapore 628884 Summary of Events CASA Holdings Limited conducted an Extraordinary General Meeting (EGM) attended by…
-
Sakae Holdings Ltd HY2026 Interim Financial Results: Revenue, Profit, and No Dividend Declared for 31 December 2025
February 14, 2026
Sakae Holdings Ltd. HY2026 Financial Review: Navigating Uncertainty in F&B Sakae Holdings Ltd. has released its unaudited condensed interim financial statements for the six months…
-
Singapore Paincare Holdings Limited HY2026 Results: Revenue Down, Reports Net Loss, No Dividend Declared for 1H FY2026
February 14, 2026
Singapore Paincare Holdings Limited (SGX: FRQ): HY2026 Interim Results Analysis Singapore Paincare Holdings Limited (“SPCH”) has released its unaudited interim consolidated financial statements for the…
🔍 View more Reports
